Literature DB >> 28066562

High density lipoproteins and kidney function: the friend turned foe?

Lina Badimon1, Gemma Vilahur2, Judit Cubedo2.   

Abstract

Year:  2016        PMID： 28066562      PMCID： PMC5179436          DOI： 10.21037/jtd.2016.11.66

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  27 in total

1.  Uremia alters HDL composition and function.

Authors:  Michael Holzer; Ruth Birner-Gruenberger; Tatjana Stojakovic; Dalia El-Gamal; Veronika Binder; Christian Wadsack; Akos Heinemann; Gunther Marsche
Journal:  J Am Soc Nephrol       Date:  2011-07-29       Impact factor: 10.121

Review 2.  The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype.

Authors:  John D Brunzell; Alberto Zambon; Samir S Deeb
Journal:  Biochim Biophys Acta       Date:  2011-09-25

3.  HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction.

Authors:  Stephen Zewinger; Thimoteus Speer; Marcus E Kleber; Hubert Scharnagl; Rainer Woitas; Philipp M Lepper; Karolin Pfahler; Sarah Seiler; Gunnar H Heine; Winfried März; Günther Silbernagel; Danilo Fliser
Journal:  J Am Soc Nephrol       Date:  2014-03-07       Impact factor: 10.121

4.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

5.  Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study.

Authors:  Marcello Tonelli; Paul Muntner; Anita Lloyd; Braden J Manns; Scott Klarenbach; Neesh Pannu; Matthew T James; Brenda R Hemmelgarn
Journal:  Lancet       Date:  2012-06-19       Impact factor: 79.321

6.  High-Density Lipoprotein Subfractions and Their Oxidized Subfraction Particles in Patients with Chronic Kidney Disease.

Authors:  Hirokazu Honda; Tsutomu Hirano; Masashi Ueda; Shiho Kojima; Shinichi Mashiba; Yasuyuki Hayase; Tetsuo Michihata; Takanori Shibata
Journal:  J Atheroscler Thromb       Date:  2015-08-18       Impact factor: 4.928

7.  Effect of long-term hemodialysis on plasma lecithin: cholesterol acyltransferase activity and the amounts and compositions of HDL2 and HDL3 in hemodialysis-treated patients with chronic renal failure: a 9-year longitudinal study.

Authors:  Khedidja Mekki; Malika Bouchenak; Mustapha Remaoun; Jacques L Belleville
Journal:  Med Sci Monit       Date:  2004-07-23

8.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).

Authors:  Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs
Journal:  Circulation       Date:  2004-08-03       Impact factor: 29.690

9.  High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans.

Authors:  Benjamin Bowe; Yan Xie; Hong Xian; Sumitra Balasubramanian; Mohamed A Zayed; Ziyad Al-Aly
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-11       Impact factor: 8.237

10.  HDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approach.

Authors:  Alain Mangé; Aurélie Goux; Stéphanie Badiou; Laure Patrier; Bernard Canaud; Thierry Maudelonde; Jean-Paul Cristol; Jérôme Solassol
Journal:  PLoS One       Date:  2012-03-21       Impact factor: 3.240
View more
  1 in total

1.  Phytosterols and Omega 3 Supplementation Exert Novel Regulatory Effects on Metabolic and Inflammatory Pathways: A Proteomic Study.

Authors:  Carmen Lambert; Judit Cubedo; Teresa Padró; Joan Sánchez-Hernández; Rosa M Antonijoan; Antonio Perez; Lina Badimon
Journal:  Nutrients       Date:  2017-06-13       Impact factor: 5.717
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.